Confined or spread disease-Extends into the skin or chest wall - Page 3 of 5 Posts on Medivizor
Navigation Menu

Confined or spread disease-Extends into the skin or chest wall Posts on Medivizor

How is hormone receptor status related to prognostic factors in metastatic breast cancer?

How is hormone receptor status related to prognostic factors in metastatic breast cancer?

Posted by on Aug 18, 2014 in Breast cancer | 0 comments

In a nutshell This paper evaluates whether prognostic factors(factors that predict outcome of disease) have different effect depending on hormone receptor status in metastatic breast cancer Some background Metastatic breast cancer (cancer that has spread) is generally incurable with a low survival rate. Several prognostic factors have been...

Read More

Pregnancy after breast cancer

Pregnancy after breast cancer

Posted by on Apr 23, 2014 in Breast cancer | 0 comments

In a nutshell This study investigated the effects of pregnancy following breast cancer diagnosis and treatment. Some background Nowadays, most breast cancer patients enjoy high survival rates and years of disease free quality of life. While the effects of breast cancer on fertility and pregnancy outcomes have been well researched, the effects of...

Read More

Chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy

Posted by on Mar 9, 2014 in Breast cancer | 0 comments

In a nutshell This review explored recent evidence regarding chemotherapy-induced peripheral neuropathy following treatment with different types of chemotherapeutic agents. Some background Chemotherapy, often used in the treatment of cancer, is well-known for its short-term toxic side-effects such as nausea or hair loss. However, symptoms of...

Read More

MammaPrint genetic testing for prediction of long-term breast cancer outcomes

Posted by on Feb 24, 2014 in Breast cancer | 0 comments

In a nutshell This study investigated the accuracy of the 70-gene signature (MammaPrint) genomic profiling test in predicting metastasis and long-term outcomes among breast cancer patients. Some background Gene-expression signature tests, such as MammaPrint, were developed in order to assess the biological action, and therefore the aggressiveness,...

Read More

Does pregnancy affect survival?

Does pregnancy affect survival?

Posted by on Nov 16, 2013 in Breast cancer | 0 comments

Does pregnancy affect survival? This study evaluated the effect of pregnancy on the survival of women with BRCA associated breast cancer. Hereditary breast cancer (associated with a mutation in either the BRCA1 or BRCA2 gene) typically presents itself in younger women. Consequently, the onset of breast cancer often overlaps with pregnancy....

Read More

Adherence to trastuzumab therapy

Adherence to trastuzumab therapy

Posted by on Sep 28, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated the use, effects and adherence of trastuzumab (herceptin) as treatment for patients with breast cancer. Some background Trastuzumab is often prescribed as adjuvant (additional) therapy for human epidermal growth factor receptor-2 positive (HER2+) breast cancer. HER2 is a protein found on the surface of some...

Read More

Pathologic complete response to neoadjuvant therapy predicts prognosis in HER2-positive breast cancer

Pathologic complete response to neoadjuvant therapy predicts prognosis in HER2-positive breast cancer

Posted by on Aug 29, 2013 in Breast cancer | 0 comments

In a nutshell This study assessed the impact of pathologic complete response (pCR) to neoadjuvant chemotherapy and trastuzumab (herceptin) on survival of HER2-positive breast cancer patients. Some background Neoadjuvant therapy refers to treatments given before surgery in order to shrink the tumor and allow for complete surgical removal of the...

Read More

Tamoxifen reduces the risk of contralateral breast cancer in women with BRCA1 or BRCA2

Posted by on Aug 25, 2013 in Breast cancer | 0 comments

In a nutshell This study examined whether tamoxifen (nolvadex) can reduce the risk of contralateral breast cancer in women diagnosed with breast cancer and the BRCA1 or BRCA2 genetic mutation. Some background The BRCA1 and BRCA2 genetic mutations are associated with a high risk of developing breast cancer. While prophylactic mastectomies (a...

Read More

The benefits of beta-blocker treatment in triple negative breast cancer patients

Posted by on Aug 21, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated the potential benefit of beta blocker treatment in triple negative breast cancer patients. In this study, patients already receiving long term treatment with beta blockers before the diagnosis of cancer were investigated to examine the effect on cancer outcome. Some background Beta blockers are a class of...

Read More